Authors:
Rueda, A
Sevilla, I
Guma, J
Ribelles, N
Miramon, J
De Las Nieves, MA
Marquez, A
Alba, E
Citation: A. Rueda et al., Secondary prophylactic C-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD, LEUK LYMPH, 41(3-4), 2001, pp. 353-358
Authors:
Germa, JR
del Muro, XG
Maroto, P
Lianes, P
Arranz, JA
Guma, J
Aparicio, J
Sastre, J
Alba, E
Terrasa, J
Saenz, A
Fernandez, A
Citation: Jr. Germa et al., Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients, MED CLIN, 116(13), 2001, pp. 481-486
Citation: E. Alba et Jm. Troya, Influence of the migration policy in parallel distributed GAs with structured and panmictic populations, APPL INTELL, 12(3), 2000, pp. 163-181
Authors:
Perez-Manga, G
Lluch, A
Alba, E
Moreno-Nogueira, JA
Palomero, M
Garcia-Conde, J
Khayat, D
Rivelles, N
Citation: G. Perez-manga et al., Gemcitabine in combination with doxorubicin in advanced breast cancer: Final results of a phase II pharmacokinetic trial, J CL ONCOL, 18(13), 2000, pp. 2545-2552
Authors:
Germa-Lluch, JR
del Muro, XG
Tabernero, JM
Sanchez, M
Aparicio, J
Alba, E
Barnadas, A
Citation: Jr. Germa-lluch et al., BOMP EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: The Spanish Germ-Cell Cancer Group experience (GG), ANN ONCOL, 10(3), 1999, pp. 289-293